Drug Research in the Dark: NIDA's Secret Grant Huddles Unveiled
Published Date: 3/17/2025
Notice
Summary
The National Institute on Drug Abuse is holding secret meetings in April and May 2025 to review important grant applications and contract proposals. These closed sessions protect private info and trade secrets while deciding on funding for research on drug abuse, new toxicology tools, and treatment devices. Researchers and companies applying for grants or contracts should watch these dates closely as funding decisions could impact their projects and budgets.
Analyzed Economic Effects
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
NIH Review for MSI Research Grants
The National Institute on Drug Abuse will hold a closed meeting on April 3, 2025 to review grant applications for the program “Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory.” If you are a researcher who applied to this NIDA program, the review and funding decision will be made at this closed session.
SBIR Review for Postmortem Toxicology Devices
A closed Special Emphasis Panel will meet on April 10, 2025 to review contract proposals for SBIR Phase II Topic 167: development of new postmortem toxicology screening devices that are portable, rapid, accurate, affordable, and accessible. Companies that submitted SBIR Phase II proposals on Topic 167 should note this review date because funding or contracting decisions will be made then.
Review of Medications and Devices for SUD
A closed panel will meet on May 12, 2025 to review and evaluate grant applications concerning medications and devices for treatment of substance use disorders (SUD). Researchers and companies that applied for NIDA grants or contracts in this area should note this date because the panel will make evaluation and funding decisions then.
Meetings Closed to Protect Confidential Info
The notice states the meetings are closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (such as patentable material), and personal information. If you apply for a NIDA grant or contract, information you submit may be kept confidential during these reviews.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12565 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re a researcher waiting on grants, these reviews shape the future of your funding and the science world!
2026-12585 — Submission for OMB Review; 30-Day Comment Request; Chimpanzee Research Use Form (Office of the Director)
The NIH wants to keep collecting info using the Chimpanzee Research Use Form and is asking the public to share thoughts by July 23, 2026. This form helps track how chimpanzees are used in research, affecting scientists and animal welfare groups. No big changes or costs are expected, just a smooth extension of the current form’s approval.
2026-12244 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
2026-12116 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important grant applications. These meetings protect private info and trade secrets while helping fund research on mice, drug development, and primate centers. Scientists and research groups applying for grants should watch for these dates as they impact funding decisions.
2026-12106 — Submission for OMB Review; 30-Day Comment Request; NIH Extramural Harassment Web Form (Office of the Director, Office of Extramural Research)
The NIH wants to keep their Extramural Harassment Web Form active so people working with NIH grants can safely report harassment. They’re asking the public to share thoughts by July 16, 2026, but no changes or costs are involved—just a smooth continuation. This helps keep NIH’s research community respectful and safe!
2026-12070 — Government Owned Inventions Available for License: Establishment and Characterization of the A1847 Human Ovarian Carcinoma Line
The National Cancer Institute is offering a special ovarian cancer cell line called A1847 for researchers to license and use. This cell line helps scientists study how ovarian cancer grows and find better treatments, especially for tough cases linked to BRCA1 gene problems. If you’re into cancer research, this is your chance to get a powerful tool starting now, with no big costs for licensing.
Previous / Next Documents
Previous: 2025-04240 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in April 2025 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re involved in these research areas, keep an eye on these dates—they shape who gets money to make science happen!
Next: 2025-04242 — National Center for Advancing Translational Sciences; Notice of Closed Meetings.
The National Center for Advancing Translational Sciences is holding a closed virtual meeting on April 3, 2025, to review special grant applications. These meetings are private to protect secret business info and personal details. This process helps decide who gets funding to support important health research.